147 related articles for article (PubMed ID: 34655179)
1. Embolization alone is as effective as TACE for unresectable HCC: systematic review and meta-analysis of randomized controlled trails.
Wang G; Zhang J; Liu H; Zheng Q; Sun P
BMC Gastroenterol; 2024 Jun; 24(1):195. PubMed ID: 38849765
[TBL] [Abstract][Full Text] [Related]
2. Compound Kushen injection combined with transarterial chemoembolization for hepatocellular carcinoma: An evidence map and overview of systematic reviews.
Lu T; Kong B; Wang Y; Yu J; Pan Y; Chen D; Li H; Chen X; Yuan Z; Yang Z; Zhang J; Ding T; Zhang G; Fan Q; Wang X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117267. PubMed ID: 37838291
[TBL] [Abstract][Full Text] [Related]
3. The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era.
Li Z; Hu Y; Zeng M; Hu Q; Ye F; Liu R; Cai H; Li Q; Wang X
Front Oncol; 2022; 12():976143. PubMed ID: 36185295
[TBL] [Abstract][Full Text] [Related]
4. Current Challenges in Image-Guided Magnetic Hyperthermia Therapy for Liver Cancer.
Sharma A; Cressman E; Attaluri A; Kraitchman DL; Ivkov R
Nanomaterials (Basel); 2022 Aug; 12(16):. PubMed ID: 36014633
[TBL] [Abstract][Full Text] [Related]
5. Interventional oncology of liver tumors: how it all started and where are we now.
Solbiati LA; Arai Y
Br J Radiol; 2022 Sep; 95(1138):20220434. PubMed ID: 35776630
[TBL] [Abstract][Full Text] [Related]
6. Local and Regional Therapies for Hepatocellular Carcinoma and Future Combinations.
Hatzidakis A; Müller L; Krokidis M; Kloeckner R
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626073
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta-analysis.
Li Z; Li Q; Wang X; Chen W; Jin X; Liu X; Ye F; Dai Z; Zheng X; Li P; Sun C; Liu X; Zhang Q; Luo H; Liu R
Cancer Med; 2021 Dec; 10(23):8432-8450. PubMed ID: 34655179
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis on radiofrequency ablation in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Cao JH; Zhou J; Zhang XL; Ding X; Long QY
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):692-700. PubMed ID: 25318879
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
Ni JY; Liu SS; Xu LF; Sun HL; Chen YT
World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ
Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
[TBL] [Abstract][Full Text] [Related]
11. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Qi X; Liu L; Wang D; Li H; Su C; Guo X
Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
Yi PS; Huang M; Zhang M; Xu L; Xu MQ
Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
[TBL] [Abstract][Full Text] [Related]
13. Potential Implications of SARS-CoV-2 Delta Variant Surges for Rural Areas and Hospitals.
Kadri SS; Simpson SQ
JAMA; 2021 Sep; 326(11):1003-1004. PubMed ID: 34383043
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
